资讯

Samsung Electronics is again facing speculations that it may spin off its foundry business from the broader semiconductor ...
Samsung Biologics, a biotech arm of South Korea's Samsung Group, said on Thursday it plans to spin off its biosimilar ...
Thwarted in her ambition to become a brewmaster, Kiran Mazumdar-Shaw channeled her frustrations into building a knockoff drug ...
Samsung Biologics Co., the biotech arm of South Korea's Samsung Group, announced Thursday that it plans to spin off its biosimilar development business to streamline its operations and focus more on ...
Samsung Biologics Co. Ltd. plans to establish a new holding company and to spin off its biosimilar division, Samsung Bioepis Co. Ltd., by October. The corporate restructuring will draw clear lines ...
Seoul: Samsung Biologics, a biotech arm of South Korea's Samsung Group, said on Thursday it plans to spin off its biosimilar development business to streamline its operations and focus on its core ...
BioLogics said in a regulatory filing that it will keep its drug contract manufacturing business while spinning off a business overseeing subsidiaries, including biosimilar drug developer Samsung ...
Samsung Biologics announced on the 22nd that it will establish 'Samsung Bioepis Holdings' through a simple spin-off method. The plan is to completely separate the contract development and ...
Samsung Biologics announced on the 22nd that it will establish 'Samsung Bioepis Holdings' through a simple spin-off method. The plan is to completely separate the contract development and ...
Shares in BioLogics, which had risen 7.1 per cent a day earlier after local media reports about a potential spin-off, rose as much as 8.2 per cent on Thursday before paring gains. Samsung C&T ...